Literature DB >> 19022154

Resistant hypertension: an overview of evaluation and treatment.

Pantelis A Sarafidis1, George L Bakris.   

Abstract

Resistant hypertension is defined as failure to achieve goal blood pressure (BP) when a patient adheres to the maximum tolerated doses of 3 antihypertensive drugs including a diuretic. Although the exact prevalence of resistant hypertension is currently unknown, indirect evidence from population studies and clinical trials suggests that it is a relatively common clinical problem. The prevalence of resistant hypertension is projected to increase, owing to the aging population and increasing trends in obesity, sleep apnea, and chronic kidney disease. Management of resistant hypertension must begin with a careful evaluation of the patient to confirm the diagnosis and exclude factors associated with "pseudo-resistance," such as improper BP measurement technique, the white-coat effect, and poor patient adherence to life-style and/or antihypertensive medications. Education and reinforcement of life-style issues that affect BP, such as sodium restriction, reduction of alcohol intake, and weight loss if obese, are critical in treating resistant hypertension. Exclusion of preparations that contribute to true BP treatment resistance, such as nonsteroidal anti-inflammatory agents, cold preparations, and certain herbs, is also important. Lastly, BP control can only be achieved if an antihypertensive treatment regimen is used that focuses on the genesis of the hypertension. An example is volume overload, a common but unappreciated cause of treatment resistance. Use of the appropriate dose and type of diuretic provides a solution to overcome treatment resistance in this instance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022154     DOI: 10.1016/j.jacc.2008.08.036

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  93 in total

1.  2010 Canadian Hypertension Education Program recommendations: An annual update.

Authors:  Norm Campbell; Margaret Moy Lum Kwong
Journal:  Can Fam Physician       Date:  2010-07       Impact factor: 3.275

Review 2.  New therapeutic approaches to resistant hypertension.

Authors:  Markus P Schlaich; Henry Krum; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 3.  Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?

Authors:  Antonios A Lazaridis; Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

4.  Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.

Authors:  Pantelis A Sarafidis; Rochelle Blacklock; Eleri Wood; Adam Rumjon; Shanique Simmonds; Jessica Fletcher-Rogers; Rachel Ariyanayagam; Aziza Al-Yassin; Claire Sharpe; Katie Vinen
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 8.237

5.  Aldosterone receptor antagonists: effective but often forgotten.

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

Review 6.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

7.  Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.

Authors:  Britta Vogel; Michael Kirchberger; Martin Zeier; Felicitas Stoll; Benjamin Meder; Daniel Saure; Martin Andrassy; Oliver J Mueller; Stefan Hardt; Vedat Schwenger; Anna Strothmeyer; Hugo A Katus; Erwin Blessing
Journal:  Clin Res Cardiol       Date:  2013-10-15       Impact factor: 5.460

8.  Renal sympathetic denervation for treatment of resistant hypertension - indigenous technique.

Authors:  Gajendra Manakshe; R Chakravarthi; Shaista Hussaini; Rajeev Menon; A Srinivas Kumar; V Ravi Kiran; Gomathi Sundar; C Narasimhan
Journal:  Indian Heart J       Date:  2013-04-19

Review 9.  Management of Resistant Hypertension Based on Recommendations from Different Guidelines and the Systolic Blood Pressure Intervention Trial.

Authors:  Sandeep Banga; Sudhir Mungee; Avani R Patel; Shantanu Singh; Tinoy J Kizhakekuttu
Journal:  Cureus       Date:  2019-08-12

10.  Regulation of renin secretion and arterial pressure during prolonged baroreflex activation: influence of salt intake.

Authors:  Drew A Hildebrandt; Eric D Irwin; Adam W Cates; Thomas E Lohmeier
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.